معرفی
Betty Pace is a Professor and holds the Tedesco Distinguished Chair in Pediatric Hematology at the Medical College of Georgia. She holds appointments in the Department of Pediatrics (Hematology/Oncology), the Georgia Cancer Center, and the Department of Biochemistry and Molecular Biology, reflecting her interdisciplinary research in hemoglobinopathies and molecular therapeutics.
Education:
- MD in Medicine, Medical College of Wisconsin, 1981
- BS in Mathematics, Marquette University, 1976
Her research focuses on epigenetic regulation of fetal globin genes, particularly through histone deacetylase inhibitors and microRNAs, aiming to develop therapies for sickle cell disease and beta thalassemia. She explores pharmacological agents like benserazide and CT-101 to reactivate fetal hemoglobin expression in erythroid progenitors.
The recent publications highlight a strong trend in translational molecular medicine, integrating microbiology, epigenetics, and pharmacology to address complications in sickle cell disease, such as acute chest syndrome and globin gene dysregulation.
Scientific Awards:
- GRU Faculty Senate Basic Science Faculty Award (2013)
- Lifetime Diversity Champion Award, University of Texas at Dallas (2010)
Betty Pace advises graduate students through her affiliation with The Graduate School and likely leads a research team focused on hemoglobin switching and gene therapy. Her work has been supported by institutional and possibly federal grants, though specific funding sources are not listed. Her leadership in pediatric hematology is underscored by her endowed chair and sustained high-impact research output.
She is actively involved in research laboratories and scientific teams within the Georgia Cancer Center and the Department of Biochemistry and Molecular Biology, where her group investigates epigenetic mechanisms and novel therapeutics for hemoglobin disorders.
